Results 121 to 130 of about 94,068 (259)

Personalized Precision in Healthcare Payment Systems: Insights From a Real‐World Cancer Patients Cohort Study

Health Care Science, EarlyView.
We developed an effective prediction model for reasonably high hospitalization costs, using gastric cancer surgery patients as an example. Integrating this assessment into the healthcare payment system based on diagnosis‐related groups is expected to improve the individualization and precision of health insurance fund utilization.
Kan Xue, Hongrui Tian, Qi Wang, Yinkui Wang, Fei Shan, Yansui Yang, Miao Yu, Zhonghu He, Ziyu Li, Jiafu Ji   +9 more
wiley   +1 more source

Preoperative prediction of Ki-67 expression in breast cancer using a combined radiomics model based on 18F-FDG PET/CT. [PDF]

Medicine (Baltimore)
Liu S, Zhang M, Yao X, Yao Y, Wang L, Xu J, Wang Q, Zhang J, Guo P, Cai H, Li J, Liu Y, Cao L.   +12 more
europepmc   +1 more source

Investigation of some structural-functional peculiarities of the immunogenic fragment Ki-67 antigen. Generation of polyclonal and monoclonal antibodies to Ki-67 [PDF]

Biopolymers and Cell, 2005
I. O. Tykhonkova, V. V. Lisogubov, Yu. V. Khozhaenko, O. O. Dovgopola, S. I. Korovin, G. V. Ovcharenko, V. S. Usenko, M. V. Rodnin, V. V. Filonenko   +8 more
openaire   +1 more source

Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma

Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source

Vasculogenic mimicry and breast cancer prognosis: Insights into predictive model development. [PDF]

Oncol Lett
Wu Z, Teng Y, Huang S, Shi S, Qiu P, Shan L, Lin M, Zhang Y.   +7 more
europepmc   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, EarlyView.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source

Investigation of immunohistochemical marker expression in breast cancer of varying severity and construction of a predictive model. [PDF]

Transl Cancer Res
Zhai Z, Chi J, Li C, Li Q, Du X, Li Y, Wang X.   +6 more
europepmc   +1 more source

Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival

International Journal of Cancer, EarlyView.
ABSTRACT Breast cancer remains a major challenge to public health. Biomarkers may be useful to improve prediction of breast cancer survival. Several epigenetic markers of cell division and ageing based on DNA methylation have been proposed. In this study, we measured these epigenetic markers in breast tumours and assessed their prognostic value.
Luca Li, Elaheh Zarean, Danmeng Lily Li, Yiyue Zhu, Shuai Li, Enes Makalic, Catriona McLean, Graham G. Giles, Roger L. Milne, Melissa C. Southey, Pierre‐Antoine Dugué   +10 more
wiley   +1 more source

Expression of p63, CD10, and Ki-67 in giant cell tumor of bone: A diagnostic immunohistochemical study. [PDF]

Medicine (Baltimore)
Youssef HMK, Hasan A, Hasan A, Sharfeldeen AERM, Samman A, Mirdad DS, Abdelwahed MS, Noorwali H, Ibrahim EH, Mohamed MMY, Rabie A, Samir M, Eldamery H, Amer A, Ebaid AEM, El-Mosely MM.   +15 more
europepmc   +1 more source